Abstracting and Indexing

  • CrossRef
  • WorldCat
  • Google Scholar
  • ResearchGate
  • Academic Keys
  • DRJI
  • Microsoft Academic
  • Academia.edu
  • OpenAIRE

Withdrawal from Glucorticosteroids Therapy: A Role for Tetracosactide 1 mg?

Author(s): Massimiliano Sansone MD, Francesco Botré MD, Francesco Romanelli MD

We present the case of a 31-year-old woman who underwent a right surrenectomy for cortical adenoma secreting cortisol responsible of Cushing’s syndrome. After surgery, she was first treated with cortisone acetate 37.5 mg/die and then with hydrocortisone 20 mg/die. Fludrocortisone was administered at the dosage of 0.05 mg/die. Patient complained of severe asthenia and drowsiness and decided to stop therapy. Reduction and subsequent withdrawal from this therapy lasted four months and it took advantage of intramuscular tetracosactide injection. One-year follow-up showed normal values of both basal and stimulated serum cortisol level; the patient was in good physical condition and did not complain any more with asthenia.

Grant Support Articles

    Editor In Chief

    Yasuo Iwasaki

  • Division of Neurology, Department of Internal Medicine
    Toho University School of Medicine
    Ota-ku, Tokyo, Japan

© 2016-2023, Copyrights Fortune Journals. All Rights Reserved!